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Executive Summary
Surgical skin antisepsis is a significant surgical site infection (SSI) prevention strategy
and choosing which one to use can be complex. Ultimately the OR nurse decides which
antiseptic to use at the point of care by assessing the patient ensuring the planned skin antisepsis
is appropriate based on allergy status, skin integrity, and surgical site. Since surgical skin
antisepsis is primarily a nursing task, understanding nursing staff’s perspectives and experiences
with prepping is key to understanding issues with its proper use and technique of application.
That is why a protocol to standardize surgical skin antisepsis geared to surgical staff by way of
teaching and compliance efforts is needed.
Alvarez (2018) discusses the need for the surgical team to be under constant training to
implement and maintain compliance with asepsis and antisepsis protocols such as validation of
competencies at least once a year including patient safety processes and quality indicators. An
educational competency tool will be provided that must be evaluated annually ensuring
standardized education and observation of technique of the surgery staff. Developing
standardized and simplified educational tools will help ensure compliance with skin antisepsis.
The evidence supporting the surgical preparation protocol policy will be reviewed and updated at
least every two years since there are always new techniques or products being evaluated and
researched. If the protocol and policy is updated, then the surgical staff must be educated and
made aware of the changes during daily morning huddles. This will allow for follow-up and
consistency with staff and physicians.
I am proposing a protocol standardizing patient skin prepping as a surgical site infection
improvement project including performing critical tasks, the same way facility wide to reduce
the risk of error and eliminate variation in processes. The research concludes that chlorhexidine
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gluconate (CHG) combined with alcohol appears to be the most effective surgical skin antiseptic,
followed by povidone-iodine and alcohol in cases where CHG is inappropriate. At the surgical
committee meeting, the findings of the literature review will be presented, and the most effective
prepping solutions will be used moving forward, surgeons’ preference cards will then be
updated, and the new guidelines from American Operating Room Nurses (AORN) will be
utilized in staff education. This meeting is based on necessity since there are still ritualistic
surgeons who need to be convinced that change needs to happen and that there are better
prepping agents available. Once everyone is on board standardizing the prepping practices will
allow for prepping technique to be in compliance and will empower the nurses to choose the
appropriate product thus reducing the risk of a surgical site infection.

STANDARDIZING SURGICAL SKIN ANTISEPSIS

6

Standardizing Surgical Skin Antisepsis
While surgical site infections hold a heavy financial burden on organizations, they all
cannot be eliminated. A reduction in the infection rate to a minimal level has significant
benefits. This will be achieved by the development of standardization of surgical site
preparation techniques, how to choose the appropriate antiseptic, re-education, and monitoring
compliance. Therefore, to ensure evidence-based practices and improved patient outcomes, there
must be continuous project support, ongoing outcome evaluation, and best practice review
throughout the organization. To assist in efforts to find the most effective antiseptic, the
following PICOT was formulated: In surgical patients (P), how does chlorhexidine gluconate
(CHG) skin preparation (I) compared to povidone-iodine (C) affect the occurrence of surgical
site infections (O) over 30 days (T)?
Rationale for the Project
According to the Centers for Disease Control and Prevention (CDC), surgical site
infection is defined as infection related to an operative procedure that occurs at or near the
surgical incision within 30 days of the procedure (Berrios-Torres et al., 2017). The prevention of
SSI is becoming increasingly important as the number of surgical procedures performed in the
United States (US) continue to rise (Berrios-Torres et al., 2017). SSIs occur in 2-5% of patients
undergoing inpatient surgery with 160,000-300,000 occurring each year in the US which
accounts for $3.5-10 billion in annual healthcare expenditures (Anderson et al., 2017). Estimates
show approximately half of SSIs are preventable by application of evidence-based strategies and
numerous recommendations from various organizations. Despite the availability of evidencebased guidelines, SSI rates have not measurably fallen, due to poor knowledge of and/or noncompliance with correct practices (Zucco, Lavano, Nobile, Papadolpoli, &Bianco, 2019).
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Preoperative skin antisepsis is one of the most critical factors for preventing
postoperative SSI, but with the lack of high-quality research, the choice of which preoperative
skin antiseptic is best remains a puzzling problem for clinicians (Chen, Chen, Guo, & Xu, 2020).
The goal of this benchmark project is aimed at implementing and standardizing a surgical skin
antiseptic protocol for the organization to utilize as a tool for staff and surgeons to be aware of
best practices according to the evidence while reducing the risk of SSIs. With that in mind
making the decision about which antiseptic to use can be complex. Therefore, input from an
interdisciplinary team with experience and knowledge of skin antiseptics is helpful during review
of current research, clinical guidelines, and information from manufacturers of the agents
(AORN, 2021).
Literature Synthesis.
Current evidence-based practices (EBP) for skin preparation play an important role in the
prevention of SSI. Many studies have evaluated their effectiveness in the prevention of SSIs by
comparing different surgical preparation solutions, such as chlorhexidine and povidone-iodine,
with and without an alcohol component. There were eleven out of twelve studies that show
chlorhexidine’s effectiveness in prevention of surgical site infection, even though they ranged
from low to moderate to high level evidence. Alcohol was an additional solution that has shown
to aid in the prevention of surgical site infection with its antimicrobial properties when used with
chlorhexidine (Dumville et al., 2015). However, in one study Xu (2017), Betadine was superior
in prevention of positive cultures, but the only surgery performed was hand surgeries. Overall,
chlorhexidine showed superior results in its efficacy to prevent surgical site infections when used
as a surgical site skin preparation before most types of surgeries. Therefore, moderate quality
evidence shows a significant benefit in reducing the risk of SSI with alcohol-based chlorhexidine
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compared to povidone-iodine. The literature supports a need for a change project of using the
most appropriate and effective skin preparation preventing SSI and making it more standardized
using evidence-based practices. According to current literature, standardizing the process of the
most effective skin antiseptic ensures reduction of microbial burden on the skin prior to surgery
with correct application each time, choosing the appropriate agent for each procedure, and
knowing what alternatives are available.
Project Stakeholders
While stakeholder support is necessary for a successful change, the facility
administrators, surgical unit staff, surgeons, patients, patients’ families, and suppliers are
impacted by this proposed change. The importance and influence of patient participation and
education is an increasingly important concept and advocated to improve patient safety in the
prevention of infection. Educating and informing patients is one way to help them understand
the evidence. Ways to educate and inform patients include preoperative teaching about best
practices to ensure patients they are receiving safe quality care. Also, standardizing the evidence
and educating stakeholders, surgeons, and staff members about surgical antiseptic use in the
prevention of surgical site infections is key to benefiting both the patients and organizations.
Nurses who are knowledgeable about surgical infections, and who use EBPs to prevent
infection, will help prevent surgical site infections. EBP increases nurse’s empowerment and
better-quality skills to combine research evidence and patient preferences into practice.
Therefore, as nurses, we are at the center of patient care, and we must listen to our patients and
provide them with options they need from the best available scientific evidence.
Multidisciplinary teams comprised of nurses, nurse leaders, surgeons, infection preventionists,
and educators all play a critical role in interprofessional involvement. A key strategy for success
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is involvement of leaders and staff who are directly affected by the potential change, including
those having difficulty accepting the change (Melnyk & Fineout-Overholt, 2019). The
gatekeepers in the organization are the administrators and chief of surgery since they oversee the
clinical protocols and hold meetings regularly discussing hospital policies and procedures.
Allies in the organization consist of other nurses concerned about EBP and improving patient
outcomes. Some barriers to EBP change include lack of knowledge and skills and social and
organizational barriers. Effective barrier assessment includes recognizing knowledge, attitudes,
and beliefs of administrators surrounding practice change and their perceived roles in
communicating support for this change. Resources needed to enact change include access to
clinical resources, personnel involved in a surgical improvement SSI committee, trainings on a
regular basis, mentors, and supplies for training. Associated costs with bringing this change to
the organization will be minimal. The multidisciplinary team of nurses and nurse educators will
carry out the change and sustain it as an ongoing learning process for the surgical department.
Implementation Plan
The major steps in the implementation plan include creating awareness and interest,
building knowledge through educating staff and patients, promoting action, and pursuing
integration and sustainability of the change. The first phase of implementation will be to
collaborate and convince the surgical staff, infection preventionists, and surgeons on which
surgical preps will be utilized by the facility, limiting product choices based on the patient
population and procedures performed following the recommended evidence guidelines and
literature reviews from AORN and other organizations such as the World Health Organization,
the National Institute for Health and Care Excellence for prevention of surgical site infection.
Next, the surgical skin antisepsis protocol will be written with the collaboration from the surgical
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committee, surgical nurses, administration, and infection preventionists. The non-approved
antiseptic products will then be removed from the Operating Rooms and inventory with only the
approved products remaining. Education and training of the staff and surgeons will then
commence with the competency tool for the nurses to complete on an annual basis along with
visual evaluation of technique which is an essential step in the reevaluation part of planning.
The infection prevention team will monitor any surgical site infections or adverse skin reactions
documented from the surgeons monthly. Then after the protocol has been in place for three
months the effectiveness will be evaluated by monitoring surgeon and staff behaviors, monthly
infection control audits, competencies, and correct documentation.
Timetable/Flowchart
The timeline for implementation takes place over a period of two weeks. During this
time the evidence will be presented, and the surgical interdisciplinary team will be educated on
the new protocol guidelines. Then after it is introduced, there will be many educational
offerings, educational posters, competency tool initiation, and meetings to discuss it further.
Then after thirty days of the protocol’s approval, reinforcement of compliance is initiated and
followed up. Three months after the protocol has been in place, the progress will be tracked by
monitoring surgical site infections, behaviors, competencies and any possible discrepancies
voiced from the team. Then finally, the protocol will be updated as needed.
Data Collection Methods
Data collection methods for this benchmark project were through studies evaluating the
most effective surgical skin antiseptic. To establish the effectiveness of the implemented
evidence-based intervention in the hospital, a thorough evaluation plan that describes and
identifies anticipated variables and outcomes will be developed. One of the outcomes for the
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project is the surgical preparation protocol that standardizes the surgical skin prep for surgical
patients. The next outcome is for nurses to comprehend and know how to choose the correct
preparation and how to apply it according to manufacturer’s guidelines. Competency will be
assessed initially and annually of the staff, monitoring for surgical site infections monthly, and
tracking staff and surgeon behavior towards this change will be ongoing. According to
Albarquouni, Hoffman, and Straus (2018), core competencies define what is expected to be able
to work optimally for health professions and to improve the quality of care by developing
assessment tools that provide a valid and reliable evaluation. Another measure of the
effectiveness is patient outcomes, in terms of reducing the incidence of surgical site infections or
adverse skin reactions from the preparation. My perceptions of the project are that this will be a
great update to the organization, and everyone will be onboard with the changes. Changing how
we choose which skin preparation is the intended purpose of this project based on the evidence
of which antiseptic solution is best for the surgical site and which one is the most effective to
prevent surgical site infection.
Cost/Benefit Discussion
Public reporting of outcome, process, and other quality improvement measures is now
required, and reimbursements for treating SSIs are being reduced or denied estimating
approximately that half of SSIs are preventable by application of evidence-based interventions
(Barrios-Torres, Umsoheid, & Bratzler, 2017). The U.S. CDC estimates approximately 1.7
million patients per year develop hospital acquired infections (HAIs) therefore, the Centers for
Medicare and Medicaid Services (CMS) have implemented quality and pay-for-performance
initiatives to reduce hospital acquired infections and hospital readmissions (Haque, Sartelli,
McKimm, & Baker, 2018). The estimated annual incidence of SSIs in the U.S. ranges from
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160,000 to 300,000, and estimated annual cost ranges from $3.5 billion to $10 billion, thus
increasing hospital stay by 9.7 days (Loyola University Health System, 2017).
There have been many advances in the reduction of HAIs through the years, but due to
the high number of deaths still occurring there needs to be more strategic polices, evidence-based
research, and routine educational initiatives focusing on prevention of SSIs. Surgical site
infections are associated with substantial morbidity, increased health care costs, and longer
hospital stay. The costs of this project are minimal, when compared to a surgical site infection
occurrence. Staff education will be done during meetings and through a competency assessment
tool so it will be done during working hours. There will be a significant implied financial
savings shown by a reduction in SSIs. Through SSI preventions, this change project improves
patient outcomes and reduces health care expenditures.
Discussion of Results
There are no results of this project currently due to the reduced number of surgical cases
being performed because of the pandemic. While the implementation of the protocol has not
been possible, the surgical department manager and surgical team have shown interest in its
implementation. With the results of most studies stating that chlorhexidine used with alcohol
was superior in the prevention of postoperative infections, the chosen prepping agent will be
chlorhexidine with alcohol or chloraprep unless contraindicated. Guidance will be provided in
the surgical antisepsis protocol policy. Once this protocol is in place, I’m hopeful that the staff
will fully understand the purpose and use of the protocol with consistent evaluation and
education resulting in an overall outcome of a decrease in surgical site infections.
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Conclusions/Recommendations
Even though there has been a lot of evidence about interventions to reduce hospital
acquired infections in recent years, there is still a large gap between the evidence and practice in
the prevention in general which means there is a need for translation and sustainability of proven
efficacious intervention (Musuuza et al., 2017). The goal for any type of surgical antiseptic
solution will be to reduce any instance of surgical infections in a safe, cost effective, and complete
manner. The hospital or organization will choose the right product that is cutting costs, is the most
effective, saving surgical time, and has the safest results for the patient. To ensure these are longlasting changes, compliance to best practices must be reinforced. Reinforcing the process by
reminding and reeducating staff of the standardized protocols and tracking prepping agents, and
site infections in the electronic medical record is a strategy to monitor compliance. Working as a
team to reduce surgical site infections should not be reliant on one element, it should be a multipronged approach to excellence within the organization. Therefore, a standardized approach that
utilizes proven products, along with reinforced compliance and tracking, will result in fewer errors,
less waste, and better-quality products for the patient and the institution.
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Appendix A

Synthesis Table

PICOT Question:
In surgical patients (P), how does chlorhexidine gluconate (CHG) skin preparation (I) as compared to povidone-iodine (C)
affect surgical site infections (O) over 30 days (T)?

Evidence Synthesis Table
Studies

Design

Sample

Intervention

Outcome

A

Meta-analysis
Review

N=2,623

-CH 4% in Al
-PI in Al
-SS & MS
-CH 2-2.5% in Al
-PIS & PIP
-PIP

-CH in Al, highest in preventing SSI (Al in the mix
added antimicrobial properties suggested by literature)
-PI in Al, moderately affective in preventing SSI
-SS & MS low results in SSI prevention
-CH 2-2.5% in Al, very low results in SSI prevention
-PIS & PIP, very low results in SSI prevention
-PIP, very low results in SSI prevention

B

Meta-analysis
Review

N=6,237

-Dr vs No Dr low quality and moderate quality
evidence
-CH vs PI low quality evidence, slightly reduced SSI
for CH rather than PI
-PI & PCMX vs PI very-low quality evidence
-Al scrub & IDr vs PI scrub without Dr very-low
quality evidence

C

Meta-analysis
Review

N=2,080

-Dr vs No Dr
-CH vs PI
-PI & PCMX vs
PI
-Al (5min scrub)
& IDr vs PI scrub
(5min scrub) w/o
Dr
-CH & Al
-PI

-CH & Al more superior than PI in SSI prevention
-CH can reduce positive culture after skin antisepsis
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Quantitative
Randomized
control trial,
Experimental
Meta-analysis
Review

N=240

-CH
-D
-B

-CH higher rate of positive cultures
-D & B lower rate of positive cultures

N=29,600

-CH superior to PI
-SAE no significant difference

F

Systematic Review
and Meta-analysis

N=19

G

Meta-analysis

H

Systematic Review
and Meta-analysis
Systematic Review
and Meta-analysis

N=8,787
CH: n=2,615
CG: n=6,172
N=3,059

-CH
-PI
-SAE
-CH
-Other
Antiseptics
-CH
-CG
-CH in Al
-PI
-EG: CH cloth
-CG: standard
disinfection
-PI
-CH

-CH in Al significant reduction in SSI, high level
evidence
-CG (standard disinfection) incidence of SSI
significantly high than in the EG (CH cloth)

-CH in Al
-PI in Al

-CH in Al, significantly lower risk of SSI
-PI in Al, low quality evidence

-PI
-CH

-CH, rate of SSI considerably lower than in PI group

E

I

J

RCT, open label
trial

K

RCT

L

RCT, Comparison
study

N=10,830
EG: n=2,593
CG: n=8,237
N=1,114
PI: n=590
CH: n=524
N=1,147
CH-Al: n=572
PI-Al: n=575
N=420
PI: n=210
CH: n=210

-CH high quality evidence
-Other no statistically significant difference
-CH high level quality evidence in SSI reduction

-PI higher rate of SSI than in CH group

Legend: A = Dumvillle et al., 2015, B = Hadiati et al., 2018, C = Angghrahita et al., 2017, D = Xu, 2017, E = Chen, 2020, F = Privitera et al.,
2016, G = Wang et al., 2017, H = Tolcher et al., 2019, I = Cai et al., 2017, J = Lakhi et al., 2018, K = Tuuli et al., 2016, L = Das et al., 2017,
Al = alcohol, B= betadine, CG = control group, CH = chlorhexidine, D = duraprep, Dr = drape, EG = experimental group, IDr = iodine drape, MS
= methylated spirits, PCMX = para-chloro-meta-xylenol PI = povidone iodine, PIP = povidone-iodine paint, PIS = povidone-iodine scrub, SAE =
skin adverse event, SSI = surgical site infection
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Flowchart

Convince with the data, create protocol
Speak to surgeons, surgery staff, infection control, and supply
about new protocol using evidence to supoort the agents that
are most effective to create the prep protocol.

Over a period of 2 weeks

Reinforce compliance of protocol
After 30 days of approved protocol

Provide educational offerings, posters, staff meetings, update
preference cards, supply to update stock, and surgeons to be
notified of changes.

Track progress
3 months

Monitor surgical site infection rate, track surgeon and staff
behavior, conduct infection control compliance audits montly,
and competencies and correct documentation.
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Instruments

Intraoperative Surgical Skin Preparation
Competency Assessment Checklist
Assessment of Competence by Assessor

Skill Criteria

Initial & Yearly assessment of
perioperative nurse
Signature/Date

Correct identification of
patient and operative site
Ensure patient allergies
checked and documented
Identify if hair removal is
necessary at surgical site
Demonstrate correct hair
removal at the surgical site
Perform preoperative skin
cleaning with CHG wipe if
appropriate
Determine which surgical
skin antiseptic is
appropriate for surgical site
and any possible
contraindications
Identify dangers of pooling
of preparation used to
disinfect the skin and how
to prevent pooling
Demonstrate correct
method of skin preparation
Demonstrate correct
documentation for skin
preparation

Comments
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SKIN ANTISEPSIS-PREOPERATIVE PATIENT
[Insert facility name or a header]

ADMINISTRATIVE APPROVAL
Date Created:
Last Date Revised:
Last Date Reviewed:
Date of Next Review:
Approval signature(s) with title and date of signature:

Signature

Title

Date

Signature

Title

Date

Signature

Title

Date

Purpose
To provide guidance to perioperative personnel for performing preoperative patient skin antisepsis. The
expected outcome is that the patient will be free from signs and symptoms of infection.

Policy
It is the policy of [insert name of facility] that:
• Preoperative patient bathing and skin antisepsis products will be approved by [facility-specific
personnel] and the product selection committee; only bathing and skin antisepsis products approved
and provided by the health care organization will be used.
• Patients will be instructed to bathe or shower before surgery with chlorhexidine gluconate.
• Hair at the surgical site will be left in place when feasible and will only be removed in select clinical
situations.
• Perioperative team members will select a safe, effective, facility-approved surgical site skin antiseptic
for the individual patient.
• Perioperative team members will apply the surgical site skin antiseptic in a safe and effective manner.
• Safety data sheets for all skin antiseptics must be readily available in the practice area.
• All personnel must follow local, state, and federal regulations for storage and disposal of flammable
skin antiseptics.

Procedure Interventions
Preoperative Patient Bathing
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Instruct the patient to bathe or shower at least once before surgery with chlorhexidine gluconate soap
o Instruct the patient to follow the product manufacturer’s instructions for use.
o Instruct the patient not to apply alcohol-based hair or skin products, lotions, emollients, or
cosmetics after the preoperative bath or shower.
o Instruct the patient not to apply deodorant when the axilla will be in the sterile field.
o Instruct the patient undergoing surgery on the hand or foot that the nails on the operative
extremity should be clean and natural, without artificial nail surfaces.
o Instruct the patient undergoing surgery on the head or neck to shampoo their hair with a facilityapproved product or shampoo.

Hair Removal
•
•
•

Instruct the patient to leave hair in place at the surgical site before surgery.
Leave hair at the surgical site in place when feasible.
If hair removal is necessary, minimize the amount to be removed, and remove hair at the surgical site
by using clipping or depilatory methods in a manner that minimizes injury to the skin.
o Remove hair as close to the start of surgery as feasible in a private location (eg, preoperative
room or bay) before entering the operating or procedure room.
o When removing hair outside the operating or procedure room is contraindicated, remove the
patient’s hair in a manner that prevents hair dispersal into the air
o Use single-use clipper heads and dispose of them after each patient use.
o Disinfect reusable clipper handles after each use, in accordance with the manufacturer’s
instructions for use.
o When using depilatories for hair removal, follow the manufacturer’s instructions for use,
including testing skin for skin allergy and irritation reactions in an area away from the surgical
site at least 24 hours before the procedure.

Surgical Site Preparation
•
•

•
•

Unless contraindicated, use an alcohol-based antiseptic.
Prior to entering the operating or procedure room, select a safe, effective, facility-approved surgical
site antiseptic for the individual patient based on the patient assessment, the surgical anatomic site,
and a review of the manufacturer’s instructions for use and contraindications.
o The perioperative RN will assess the patient’s
▪ allergies and sensitivities to preoperative skin antiseptics,
▪ skin pigmentation (ie, fair, medium-fair, medium-dark, dark),
▪ skin integrity at the surgical site, and
▪ surgical site for the presence of hair.
o The perioperative RN will consult the physician when selecting
▪ iodine and iodophor-based antiseptics for patients susceptible to iodism or
▪ chlorhexidine gluconate and alcohol-based antiseptics for neonates.
o Perioperative team members will collaboratively evaluate the risks and benefits of using an
alternative antiseptic product when facility-approved antiseptic products are contraindicated for
the individual patient.
Perioperative team members will confirm the surgical site before the surgical site antiseptic is
applied.
The perioperative RN will assess the condition of the patient’s skin at the surgical site and prepare the
skin for antisepsis.
o Wash skin at the surgical site with a facility-approved product or soap when soil, debris,
emollients, cosmetics, or alcohol-based products are present.
o Remove the patient’s jewelry at the surgical site before skin antisepsis.
o If soiled, cleanse the areas in the surgical site that are of greater contamination than the
surrounding area (eg, umbilicus, foreskin, under nails, intestinal or urinary stoma) prior to
beginning surgical site preparation.
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Isolate highly contaminated areas (eg, anus, colostomy) that are near the surgical site with a
sterile barrier drape.
A nonscrubbed perioperative team member will apply the skin antiseptic using sterile technique
according to the manufacturer’s instructions for use.
o Perform hand hygiene.
o Wear sterile gloves (nonsterile gloves may be worn if the antiseptic applicator is of sufficient
length to prevent contact of the gloved hand with the antiseptic solution and the patient’s skin).
o Use sterile supplies to apply the antiseptic.
o When using a pre-filled antiseptic applicator, follow manufacturer’s instructions for maximum
and minimum surface area per applicator.
o Use radiopaque sponges to apply antiseptic when pre-filled antiseptic applicators or pre-packaged
sponge kits are not available.
o Apply the antiseptic to an area large enough to accommodate potential shifting of the surgical
drapes, extension of the incision (eg, during conversion of a minimally invasive procedure to an
open procedure), potential additional incisions, and all potential drain sites.
o Apply the antiseptic starting at the incision site and moving toward the periphery of the surgical
site.
▪ For an incision site that is more contaminated than the surrounding skin (eg, perineum), prep
the area with lower bacterial count first, followed by the area of higher contamination, as
opposed to working from the incision toward the periphery.
▪ When performing procedures with different wound classifications (eg abdominal-perineal)
complete two separate surgical site preparations and prep the more contaminated site first.
o Discard the applicator after contact with a peripheral or contaminated area. Use another sterile
applicator for additional antiseptic applications.
o Apply the antiseptic with care on fragile tissue, burns, open wounds, or malignant areas.
o Cover all surfaces of the skin in the surgical field (e.g., areas between fingers or toes, when
applicable).
o Take protective measures to prevent prolonged contact with skin antiseptics.
▪ Protect sheets, padding, and positioning equipment from dripping or pooling of the skin
antiseptic beneath and around the patient.
▪ Protect electrodes (e.g., electrocardiogram, electrosurgical unit dispersive electrode) and
tourniquets from contact with the skin antiseptic.
▪ For the patient in lithotomy position, place a fluid-resistant pad under the patient’s buttocks
during perineal surgical site preparation.
o Allow the antiseptic to dry for the full time recommended in the manufacturer’s instructions for
use before sterile drapes are applied.
Take protective measures to minimize the risk of fire when flammable antiseptics are used.
o Do not heat flammable skin antiseptics.
o Prevent antiseptics from pooling or soaking into linens for the patient’s hair by
▪ Using reusable or disposable sterile towels to absorb drips and excess solution during
application,
▪ removing materials that are saturated with the skin antiseptic from the patient care vicinity
before the patient is draped, and
▪ wicking excess solution with a sterile towel to help dry the surgical prep area completely.
o Allow time for the antiseptic to dry completely and for any fumes to dissipate before surgical
drapes are applied or a potential ignition source is used.
o Communicate use of flammable antiseptics as part of the fire risk assessment involving the entire
perioperative team before the surgical procedure begins.
At the end of the surgical procedure, remove the skin antiseptic from the patient’s skin before
application of an occlusive dressing or tape unless otherwise indicated by the manufacturer’s
instructions for use.
The perioperative RN will assess the patient’s skin for injury after surgery.
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Depending on the patient’s condition, a thorough evaluation of the patient’s skin may be
postponed until the patient is transferred to the postoperative area.
All personnel will review and follow the skin antiseptic manufacturer’s instructions for use and safety
data sheets for handling, storing, and disposing of skin antiseptics.
o Store skin antiseptics in the original, single-use container.
o Do not dilute skin antiseptics after opening.
o Discard skin antiseptics in single-use containers after each use and do not refill.
o Only heat nonflammable skin antiseptics in accordance with the manufacturer’s instructions for
use.
o Do not warm skin antiseptics in a microwave oven or steam sterilizer.
o

•

Documentation
•

The perioperative RN will document hair removal in the patient’s health care record, including
o person performing hair removal,
o hair removal method,
o time of removal, and
o area of hair removal.

•

The perioperative RN will document preoperative patient skin antisepsis in the patient’s health care
record, including
o removal and disposition of any jewelry.
o condition of the skin at the surgical site (e.g., presence of rashes, skin eruptions, abrasions,
redness, irritation, burns).
o antiseptic used.
o person performing preoperative patient skin antisepsis.
o area prepped; and
o postoperative skin condition, including any skin irritation, hypersensitivity, or allergic response to
preparation solutions.

Competency
Perioperative personnel will receive education and complete competency verification activities on
preoperative patient skin antisepsis.

Quality
Perioperative personnel will participate in quality assurance and performance improvement activities on
preoperative patient skin antisepsis.

Glossary
Antiseptic: A product with antimicrobial activity that is applied to the skin to reduce the number of
microbial flora.
Iodism: Poisoning by iodine, a condition marked by severe rhinitis, frontal headache, emaciation,
weakness, and skin eruptions. Caused by the administration of iodine or one of the iodides.
Patient care vicinity: A space in a location intended for the examination and treatment of patients that
extends 1.8 m (6 ft) beyond the normal location of the bed, chair, table, treadmill, or other device that
supports the patient during examination and treatment and extends vertically to 2.3 m (7 ft 6 inches)
above the floor.

STANDARDIZING SURGICAL SKIN ANTISEPSIS

24

Preoperative bathing: A standardized regimen to reduce skin surface pathogens that is performed by
showering or bathing/washing with an antiseptic or soap prior to surgical or other invasive procedures.
Surgical site preparation: Preoperative treatment of the patient’s skin in the operating or procedure room
that includes not only the immediate site of the intended surgical incision but also a broader area of the
patient’s skin.
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Appendix: Facility-Approved Products
Preoperative Patient Bathing
Unless contraindicated, chlorhexidine gluconate (CHG) is the preferred product for preoperative patient
bathing.

Patient Skin Antisepsis
The following preoperative patient skin antiseptics are approved for use:
• chlorhexidine gluconate-alcohol, or chloraprep
• povidone-iodine alcohol, or duraprep
• aqueous iodine/iodophors (10%), and
• chlorhexidine gluconate (CHG) (4%).
• Chloroxylenol topical
Unless contraindicated Chloraprep-chlorhexidine gluconate-alcohol is the preferred antiseptic for
preoperative patient skin antisepsis.
• For vaginal antisepsis, aqueous iodine/iodophor (10%) is preferred. If patient is allergic to iodine, use
of 4% Chlorhexidine gluconate is preferred.
• For open wounds: iodine/iodophor (10%) is preferred
• For eye antisepsis, 5% povidone-iodine is preferred. If patient is allergic to iodine, use of
Chloroxylenol topical around the eye and rinse the eye with warm saline is preferred.
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